Colm R. Duffy

3.1k total citations · 1 hit paper
11 papers, 2.3k citations indexed

About

Colm R. Duffy is a scholar working on Immunology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Colm R. Duffy has authored 11 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 2 papers in Psychiatry and Mental health. Recurrent topics in Colm R. Duffy's work include Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (7 papers) and Immunotherapy and Immune Responses (5 papers). Colm R. Duffy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immune cells in cancer (7 papers) and Immunotherapy and Immune Responses (5 papers). Colm R. Duffy collaborates with scholars based in United States, Canada and France. Colm R. Duffy's co-authors include James P. Allison, Spencer C. Wei, Stephen Mok, Cristian Coarfa, Casey R. Ager, Maria Emilia Di Francesco, Michael A. Curran, Kimal Rajapakshe, Rishika Prasad and Philip Jones and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Cancer Discovery.

In The Last Decade

Colm R. Duffy

11 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

2018 2.2k citations Spencer C. Wei, Colm R. Duffy et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colm R. Duffy United States	4	1.6k	1.1k	514	394	209	11	2.3k
Dario Sangiolo Italy	25	1.4k 0.8×	1.1k 1.0×	549 1.1×	442 1.1×	200 1.0×	76	2.2k
Jesse M. Zaretsky United States	8	1.5k 0.9×	1.3k 1.2×	518 1.0×	278 0.7×	183 0.9×	16	2.1k
Kim C. Ohaegbulam United States	14	1.2k 0.7×	884 0.8×	416 0.8×	339 0.9×	180 0.9×	19	1.8k
Sofia R. Gameiro United States	28	1.9k 1.1×	1.5k 1.4×	609 1.2×	556 1.4×	208 1.0×	59	2.7k
Yu Kato Japan	15	1.8k 1.1×	1.5k 1.3×	472 0.9×	348 0.9×	215 1.0×	30	2.7k
Karsten A. Pilones United States	16	1.4k 0.9×	1.1k 1.0×	449 0.9×	342 0.9×	236 1.1×	41	2.0k
Max D. Wellenstein Netherlands	9	1.3k 0.8×	1.3k 1.1×	691 1.3×	307 0.8×	394 1.9×	10	2.3k
Simon J. Dovedi United Kingdom	24	2.0k 1.2×	1.4k 1.2×	416 0.8×	578 1.5×	180 0.9×	60	2.8k
Lawrence P. Andrews United States	11	1.3k 0.8×	1.1k 1.0×	392 0.8×	244 0.6×	159 0.8×	14	1.9k
Todd T. Moore United States	12	1.8k 1.1×	1.4k 1.3×	686 1.3×	257 0.7×	373 1.8×	17	2.8k

Countries citing papers authored by Colm R. Duffy

Since Specialization

Citations

This map shows the geographic impact of Colm R. Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colm R. Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colm R. Duffy more than expected).

Fields of papers citing papers by Colm R. Duffy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colm R. Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colm R. Duffy. The network helps show where Colm R. Duffy may publish in the future.

Co-authorship network of co-authors of Colm R. Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Colm R. Duffy. A scholar is included among the top collaborators of Colm R. Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colm R. Duffy. Colm R. Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Ager, Casey R., Kimal Rajapakshe, Maria Emilia Di Francesco, et al.. (2021). High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Journal for ImmunoTherapy of Cancer. 9(8). e003246–e003246. 47 indexed citations

2.

Mok, Stephen, Colm R. Duffy, Nana-Ama A.S. Anang, & James P. Allison. (2020). Abstract A23: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse. Cancer Research. 80(19_Supplement). A23–A23. 1 indexed citations

3.

Mok, Stephen, Colm R. Duffy, & James P. Allison. (2018). Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse. The Journal of Immunology. 200(Supplement_1). 122.2–122.2. 1 indexed citations

4.

Mok, Stephen, Colm R. Duffy, & James P. Allison. (2018). Abstract 2984: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse. Cancer Research. 78(13_Supplement). 2984–2984. 3 indexed citations

5.

Wei, Spencer C., Colm R. Duffy, & James P. Allison. (2018). Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discovery. 8(9). 1069–1086. 2200 indexed citations breakdown →

6.

Duffy, Colm R., Stephen Mok, & James P. Allison. (2018). Blocking colony stimulating factor 1 receptor (CSF-1R) and tropomyosin receptor kinase A (TrkA) improves the antitumor efficacy of immune checkpoint blockade. The Journal of Immunology. 200(Supplement_1). 122.15–122.15. 1 indexed citations

7.

Mok, Stephen, Colm R. Duffy, & James P. Allison. (2017). Abstract 1685: Effects of anti-ctla-4 and anti-pd-1 on memory T-cell differentiation and resistance to tumor relapse. Cancer Research. 77(13_Supplement). 1685–1685. 2 indexed citations

8.

Mok, Stephen, et al.. (2017). Abstract PR01: Blocking Colony Stimulating Factor 1 Receptor (CSF-1R) and Tropomyosin Receptor Kinase (Trk) improves antitumor efficacy of immunotherapy. Cancer Immunology Research. 5(3_Supplement). PR01–PR01. 4 indexed citations

9.

Mok, Stephen, et al.. (2016). Abstract A146: Increase antitumor activity of immunotherapy by blocking colony stimulating factor 1 receptor and tropomyosin receptor kinase. Cancer Immunology Research. 4(11_Supplement). A146–A146. 3 indexed citations

10.

Shawler, Daniel L., Richard M. Bartholomew, Richard Trauger, et al.. (2002). Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clinical & Experimental Immunology. 129(1). 99–106. 18 indexed citations

11.

Duffy, Colm R., et al.. (1978). Factor VIII Procoagulant and Antigen Content of Antihemophilic Factor (AHF) Concentrates. Transfusion. 18(6). 747–749. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact